Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 3/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5548611 | 0.98 | CYP1A2 (0.41) | CYP1A2CNR1CNR2MEN1KMT2A | |
| SCHEMBL5029785 | 0.86 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL5028331 | 0.84 | CYP1A2 (0.34) | CYP1A2EPHX1 | |
| SCHEMBL5034189 | 0.82 | CYP1A2 (0.38) | CYP1A2CNR1CNR2MEN1KMT2A | |
| SCHEMBL5029823 | 0.80 | CYP1A2 (0.41) | CYP1A2CNR1CNR2MEN1KMT2A | |
| SCHEMBL15914934 | 0.76 | CYP1A2 (0.41) | CYP1A2CNR1CNR2MEN1KMT2A | |
| SCHEMBL5034192 | 0.75 | — | — | |
| SCHEMBL846790 | 0.74 | CYP1A2 (0.39) | CYP1A2CNR1CNR2MEN1KMT2A | |
| SCHEMBL15915019 | 0.74 | CYP1A2 (0.44) | CYP1A2CNR1CNR2MEN1KMT2A | |
| SCHEMBL3898468 | 0.74 | CYP1A2 (0.44) | CYP1A2CNR1CNR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1999167-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | Novolen Technology Holdings, C.V. (NL) | 2008-12-10 | — | — | EP | disclosed |
| WO-2007106348-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213204-A1 | Ziegler-Natta catalyst with in situ-generated donor | NOVOLEN TECHNOLOGY HOLDINGS C.V. | 2007-09-13 | — | — | US | disclosed |